Researcher
Claus Bachert
- Disciplines:Allergology
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → 30 Sep 2022 - Department of Otorhinolaryngology (Department)
Member
From1 Oct 1998 → 30 Sep 2018
Projects
1 - 10 of 31
- Role of IL-33 and SERPINB4 in the exacerbations of airway inflammation, induced by viral- or bacterial-derived pathogensFrom1 Nov 2019 → 31 Oct 2023Funding: FWO Strategic Basic Research Grant
- Protease dependent regulation of IL-33 activity in allergic airway inflammationFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Understanding Heterogeneity of Eosinophils in Airway DiseaseFrom1 Jan 2018 → 31 Dec 2021Funding: FWO EOS
- Eosinophils in upper airway inflammation : the good, the bad or the ugly? A study on the role of staphylococcus aureus in the interactions and plasticity of eosinophils and their products in upper airway inflammation.From1 Oct 2017 → 29 Feb 2020Funding: FWO fellowships
- Investigation of the role and interaction of eosinophil extracellular traps and Staphylococcus Aureus in chronic rhinosinusitisFrom1 Jan 2016 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Peroxisomes in mast cells – their functions and link to airway inflammationFrom1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships, BOF - Other initiatives
- Identification of immunomodulating factors affecting T cell plasticity in upper airwaysFrom1 Mar 2014 → 30 Nov 2016Funding: BOF - Other initiatives
- The role of peroxisomes in inflammation and cell deathFrom1 Jan 2014 → 31 Oct 2019Funding: BOF - Concerted Research Project from 1994
- Role of purinergic signaling in the pathophysiology of human chronic upper airway inflammationFrom1 Sep 2013 → 28 Feb 2014Funding: BOF - Doctoral projects
- S100A8/A9, HMGB1 and their common receptors in the pathophysiology of human chronic airway inflammationFrom1 Mar 2013 → 31 Dec 2017Funding: BOF - Doctoral projects
Publications
11 - 20 of 674
- Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?(2022)Volume: 149
Authors: Tim Delemarre, Elien Gevaert, Gabriële Holtappels, Nan Zhang, Hans Nauwynck, Claus Bachert
Pages: AB161 - AB161 - Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)(2022)
Authors: Claus Bachert, Jorge Fernando Maspero, Mandy Cuevas, David Steele, Sandip Acharya, Pablo Altman
Pages: 1675 - 1682.e3 - Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers(2022)
Authors: Debbie J. Maurer, Chengyao Liu, Paraskevi Xepapadaki, Barbara Stanic, Claus Bachert, Susetta Finotto, YaU+2010Dong Gao, Anna Graser, Tuomas Jartti, Walter Kistler, et al.
Pages: 1216 - 1230 - Empfehlungen zur Überprüfung der Wirksamkeit und Verlaufsdokumentation von Dupilumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem(2022)
Authors: L. Klimek, U. Förster-Ruhrmann, H. Olze, A. G. Beule, A. M. Chaker, J. Hagemann, T. Huppertz, T. K. Hoffmann, S. Dazert, T. Deitmer, et al.
Pages: 855 - 865 - Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies(2022)
Authors: Bob Geng, Claus Bachert, William W. Busse, Stella E. Lee, Michael S. Niederman, Zhen Chen, Xin Lu, Faisal A. Khokhar, Upender Kapoor, Nami Pandit-Abid, et al.
Pages: 732 - 741 - A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion(2022)
Authors: Zaichuan Wang, Qiqi Wang, Su Duan, Yuling Zhang, Limin Zhao, Shujian Zhang, Liusiqi Hao, Yan Li, Xiangdong Wang, Chenshuo Wang, et al.
- Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial(2022)Volume: 149
Authors: Lucia de Prado Gomez, Asif Hameed Khan, Anju Peters, Claus Bachert, Martin Wagenmann, Enrico Heffler, Claire Hopkins, Peter Hellings, Mei Zhang, Jun Xing, et al.
Pages: AB49 - AB49 - Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study(2022)
Authors: Rebecca Saenz, Jonathan Corren, Joseph K. Han, Joaquim Mullol, Stella E. Lee, Randall A. Ow, Rui Zhao, Monet Howard, Kit Wong, Lutaf Islam, et al.
Pages: 957 - 965.e3 - Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds(2022)
Authors: ChienU+2010Chia Chuang, Isabelle Guillemin, Claus Bachert, Stella E. Lee, Peter Hellings, Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.
Pages: 259 - 264 - IL-10 family cytokines in chronic rhinosinusitis with nasal polyps : from experiments to the clinic(2022)
Authors: Lijia Xuan, Nan Zhang, Xiangdong Wang, Luo Zhang, Claus Bachert